← Open Payments lookup

TAMARA LAURITZEN: Open Payments

NPI 1801546494 · MANCHESTER, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$761 in 51 payments from 9 companies in 2025. Trend: 2023 $326 · 2024 $678 · 2025 $761

Food & beverage: $761
CompanyPaymentsAmount
ABBVIE INC.16$179
Neurocrine BioSciences, Inc.14$171
Otsuka America Pharmaceutical, Inc.7$148
E.R. Squibb & Sons, L.L.C.5$88
Janssen Pharmaceuticals, Inc3$72
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$41
Teva Pharmaceuticals USA, Inc.2$29
Axsome Therapeutics, Inc.1$17
Collegium Pharmaceutical, Inc.1$15

Products named: VRAYLAR, INGREZZA, COBENFY, REXULTI, ABILIFY ASIMTUFII, INVEGA SUSTENNA, CAPLYTA, ABILIFY MAINTENA.

Industry payments across IA — which companies pay providers there.